Found: 6
Select item for more details and to access through your institution.
Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The impact of prognosis without treatment on doctors' and patients' resource allocation decisions and its relevance to new drug recommendation processes.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, n. 2, p. 224, doi. 10.1111/j.1365-2125.2007.02996.x
- By:
- Publication type:
- Article
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5839, doi. 10.3390/cancers13225839
- By:
- Publication type:
- Article
Patient perceptions of their decision to undergo palliative chemotherapy in the Edinburgh Cancer Centre.
- Published in:
- Journal of the Royal College of Physicians of Edinburgh, 2019, v. 49, n. 3, p. 199, doi. 10.4997/JRCPE.2019.306
- By:
- Publication type:
- Article
Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratification.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00187-y
- By:
- Publication type:
- Article
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18819-5
- By:
- Publication type:
- Article